K. Rajasekaran
Papers
1
Total Citations
2
H-Index
1
About
Dr. K. Rajasekaran is a leading oncologic surgeon whose work centers on de-intensification strategies for HPV-related oropharyngeal cancers, with a particular focus on transoral robotic surgery (TORS). His most impactful contribution, detailed in a 2022 Phase II study, demonstrates that carefully selected patients with p16+ oropharyngeal squamous cell carcinoma can safely undergo volume and dose reduction of adjuvant therapy following TORS and neck dissection, thereby minimizing long-term treatment toxicities without compromising oncologic outcomes. This work has garnered early attention with 2 citations, reflecting its emerging influence in reshaping standard-of-care protocols. Dr. Rajasekaran’s research bridges surgical innovation and personalized medicine, offering a paradigm shift away from aggressive chemoradiation toward a more tailored, function-preserving approach. His findings are particularly relevant for students and clinicians exploring de-escalation trials, as they provide a rigorous framework for balancing cure rates with quality of life. By championing evidence-based de-intensification, Dr. Rajasekaran is helping define the next generation of head and neck cancer management.
Research Focus
Key Achievements
Top Papers
- 1